CPB Campbell's (CPB) Insider Trading, Ownership & Congress Trades
Food & Beverage · Food and kindred products · CIK 0000016732
Congress · 1
Funds added, last quarter
392
13F, latest reported quarter
What the filings say about CPB
Insiders, 180 days
+$2.1K net bought
1 buyer
Congress, 1 year
1 bought · 1 sold
Latest: purchase, 2026-05-15
Campbell's insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CAMPBELL'S Co insiders bought a net $2.1K of stock across 19 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 100.0% of the 100 shares held after it.
- No other insider bought within 30 days.
- 392 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Dorrance Bennett JR bought about $2.1K of CPB on Jun 9, 2026, the largest insider purchase at the company on our record; 392 funds added in the latest 13F quarter.Context
- 6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Jan 3, 2025.
- The trade is 10.7% of the 25,264 shares held after it.
- 1 other insider sold within 30 days.
- 392 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Chief Comms Officer Sanzio Anthony sold about $71.6K of CPB on Jan 9, 2026; 1 other insider sold within 30 days and 392 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Mar 31, 2025.
- The trade is 26.4% of the 43,777 shares held after it.
- 1 other insider sold within 30 days.
- 392 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Gen Counsel, and Corp Sec Brawley Charles A. III sold about $325.1K of CPB on Dec 30, 2025, the largest insider sale at the company since 2024; 1 other insider sold within 30 days and 392 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 6.6% of the 37,590 shares held after it.
- No other insider sold within 30 days.
- 392 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Gen Counsel, and Corp Sec Brawley Charles A. III sold about $100.0K of CPB on Mar 31, 2025; 392 funds added in the latest 13F quarter.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Oct 3, 2024.
- The trade is 12.1% of the 16,551 shares held after it.
- No other insider sold within 30 days.
- 392 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Vice President Sanzio Anthony sold about $83.8K of CPB on Jan 3, 2025; 392 funds added in the latest 13F quarter.19 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net +$2.1K over 180 days
more than 58% of Food & Beverage
Congress
1 member bought in the last year
the lowest in Food & Beverage
Funds
392 funds bought in last quarter
more than 82% of Food & Beverage
Revenue
-5.0% year over year
below 73% of Food & Beverage
Margin
4.1% net margin
more than 56% of Food & Beverage
Buybacks
$26.0M repurchased, FY to 2026-08-02
below 66% of Food & Beverage
Short interest
18.6% of the float short (float per yahoo 2026-10-26) · 5.0 days to cover · settled 2026-09-30
more than 88% of Food & Beverage
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch CPB
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-30.6%12M
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CPB: institutional holders (13F)
13F holdings, latest reported quarter
29,225,401 sh
$650.8M
12,422,314 sh
$276.6M
9,255,680 sh
$206.1M
8,554,455 sh
$190.5M
8,046,417 sh
$179.2M
Congress trades in CPB
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Bought 2026-05-15 · disclosed 24 days later
$1,001 - $15,000
Bought 2025-12-30 · disclosed 13 days later
$50,001 - $100,000
Sold 2025-12-19 · disclosed 24 days later
$1,001 - $15,000
Bought 2025-11-18 · disclosed 27 days later
$1,001 - $15,000
Sold 2025-06-17 · disclosed 57 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CPB planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
CPB mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
WBI Power Factor High Dividend ETF
$3.0M position · as of 2026-06-30
5.1%
Brandes Small Cap Value Fund
$20.7M position · as of 2026-06-30
3.2%
First Trust Consumer Staples AlphaDEX Fund
$7.4M position · as of 2026-07-31
3.2%
First Trust Nasdaq Food & Beverage ETF
$584.1K position · as of 2026-06-30
2.5%
Monteagle Select Value Fund
$477.1K position · as of 2026-05-31
2.4%
Hillman Value Fund
$1.7M position · as of 2026-06-30
2.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mark Clouse
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$12.3M
$17.4M
$4.1M
+18%
+6%
2023
$11.7M
$11.1M
$3.8M
+13%
+19%
2022
$10.3M
$13.0M
$4.0M
+17%
+13%
2021
$9.9M
$3.6M
$3.4M
-9%
+7%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $2.1K bought by insiders over 180 days, 392 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade. Each figure is a federal filing, dated the day it went public.
CPB financials
Revenue growth
-5.0%
XBRL, annual
Net margin
4.1%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$9.7B
four quarters, 2025-08-04 to 2026-08-02
Revenue, TTM CPB
| FY Aug 2026 | $9.7B |
| FY Aug 2025 | $10.3B |
| FY Jul 2024 | $9.6B |
| FY Jul 2023 | $9.4B |
| FY Jul 2022 | $8.6B |
| Aug 2026 | $2.1B |
| May 2026 | $2.4B |
| Feb 2026 | $2.6B |
| Nov 2025 | $2.7B |
| Aug 2025 | $2.3B |
| Apr 2025 | $2.5B |
| Jan 2025 | $2.7B |
| Oct 2024 | $2.8B |
At each fiscal year end
Single quarter
Net margin, TTM
+4.2%
net income over revenue, 2025-08-04 to 2026-08-02
Net margin, TTM CPB
| FY Aug 2026 | +4.2% |
| FY Aug 2025 | +5.9% |
| FY Jul 2024 | +5.9% |
| FY Jul 2023 | +9.2% |
| FY Jul 2022 | +8.8% |
| Aug 2026 | -2.7% |
| May 2026 | +5.2% |
| Feb 2026 | +5.7% |
| Nov 2025 | +7.2% |
| Aug 2025 | +6.2% |
| Apr 2025 | +2.7% |
| Jan 2025 | +6.4% |
| Oct 2024 | +7.9% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$678.0M
operating cash flow minus capex, 2025-08-04 to 2026-08-02
Free cash flow, TTM CPB
| FY Aug 2026 | $678.0M |
| FY Aug 2025 | $705.0M |
| FY Jul 2024 | $668.0M |
| FY Jul 2023 | $773.0M |
| FY Jul 2022 | $939.0M |
| Aug 2026 | $136.0M |
| May 2026 | $29.0M |
| Feb 2026 | $416.0M |
| Nov 2025 | $97.0M |
| Aug 2025 | $129.0M |
| Apr 2025 | $50.0M |
| Jan 2025 | $411.0M |
| Oct 2024 | $115.0M |
At each fiscal year end
Single quarter
Debt to equity
1.85x
long-term 2026-08-02 plus current 2026-08-02; equity 2026-08-02
Debt to equity CPB
| FY Aug 2026 | 1.85x |
| FY Aug 2025 | 1.76x |
| FY Jul 2024 | 1.89x |
| FY Jul 2023 | 1.28x |
| FY Jul 2022 | 1.44x |
| Aug 2026 | 1.85x |
| May 2026 | 1.74x |
| Feb 2026 | 1.77x |
| Nov 2025 | 1.76x |
| Aug 2025 | 1.76x |
| Apr 2025 | 1.78x |
| Jan 2025 | 1.96x |
| Oct 2024 | 2.06x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.15x
TTM operating cash flow over long-term 2026-08-02 plus current 2026-08-02
Cash flow to debt CPB
| FY Aug 2026 | 0.15x |
| FY Aug 2025 | 0.16x |
| FY Jul 2024 | 0.16x |
| FY Jul 2023 | 0.24x |
| FY Jul 2022 | 0.25x |
| Aug 2026 | 0.15x |
| May 2026 | 0.16x |
| Feb 2026 | 0.16x |
| Nov 2025 | 0.16x |
| Aug 2025 | 0.16x |
| Apr 2025 | 0.17x |
| Jan 2025 | 0.16x |
| Oct 2024 | 0.16x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+10.4%
TTM net income over average of 2025-08-03 and 2026-08-02
Return on equity CPB
| FY Aug 2026 | +10.4% |
| FY Aug 2025 | +15.6% |
| FY Jul 2024 | +15.2% |
| FY Jul 2023 | +24.5% |
| FY Jul 2022 | +23.4% |
| Aug 2026 | +10.4% |
| May 2026 | +15.4% |
| Feb 2026 | +13.9% |
| Nov 2025 | +14.8% |
| Aug 2025 | +15.6% |
| Apr 2025 | +11.7% |
| Jan 2025 | +13.4% |
| Oct 2024 | +14.5% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.7%
TTM net income over average of 2025-08-03 and 2026-08-02
Return on assets CPB
| FY Aug 2026 | +2.7% |
| FY Aug 2025 | +4.0% |
| FY Jul 2024 | +4.2% |
| FY Jul 2023 | +7.2% |
| FY Jul 2022 | +6.4% |
| Aug 2026 | +2.7% |
| May 2026 | +4.1% |
| Feb 2026 | +3.5% |
| Nov 2025 | +3.7% |
| Aug 2025 | +4.0% |
| Apr 2025 | +3.0% |
| Jan 2025 | +3.7% |
| Oct 2024 | +3.9% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+6.1%
operating income after a 23.4% effective tax rate, over long-term 2026-08-02 plus current 2026-08-02 plus average of 2025-08-03 and 2026-08-02 minus cash
Return on invested capital CPB
| FY Aug 2026 | +6.1% |
| FY Aug 2025 | +8.0% |
| FY Jul 2024 | +7.0% |
| FY Jul 2023 | +12.4% |
| FY Jul 2022 | +11.3% |
| Aug 2026 | +6.1% |
| May 2026 | +8.0% |
| Feb 2026 | +7.7% |
| Nov 2025 | +7.9% |
| Aug 2025 | +8.0% |
| Apr 2025 | +6.5% |
| Jan 2025 | +6.8% |
| Oct 2024 | +6.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+7.0%
operating income (EBIT proxy) over average of 2025-08-03 and 2026-08-02 minus current liabilities
Return on capital employed CPB
| FY Aug 2026 | +7.0% |
| FY Aug 2025 | +9.5% |
| FY Jul 2024 | +9.3% |
| FY Jul 2023 | +13.9% |
| FY Jul 2022 | +12.3% |
| Aug 2026 | +7.0% |
| May 2026 | +9.2% |
| Feb 2026 | +8.3% |
| Nov 2025 | +8.9% |
| Aug 2025 | +9.5% |
| Apr 2025 | +7.8% |
| Jan 2025 | +9.0% |
| Oct 2024 | +8.9% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
15.95x
close 2026-10-23 over four quarters of diluted EPS, 2025-08-04 to 2026-08-02
P/E, trailing CPB
| FY Aug 2026 | 16.91x |
| FY Aug 2025 | 16.08x |
| FY Jul 2024 | 24.87x |
| FY Jul 2023 | 16.23x |
| FY Jul 2022 | 19.66x |
| Aug 2026 | 16.91x |
| May 2026 | 10.21x |
| Feb 2026 | 15.21x |
| Nov 2025 | 15.53x |
| Aug 2025 | 16.08x |
| Apr 2025 | 24.19x |
| Jan 2025 | 22.66x |
| Oct 2024 | 25.86x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$12.9B
market value at close 2026-10-23 on 2026-09-16 shares, plus long-term 2026-08-02 plus current 2026-08-02, minus cash 2026-08-02
Enterprise value CPB
| FY Aug 2026 | $13.3B |
| FY Aug 2025 | $16.4B |
| FY Jul 2024 | $21.0B |
| FY Jul 2023 | $18.3B |
| FY Jul 2022 | $19.5B |
| Aug 2026 | $13.3B |
| May 2026 | $12.8B |
| Feb 2026 | $14.9B |
| Nov 2025 | $15.8B |
| Aug 2025 | $16.4B |
| Apr 2025 | $17.6B |
| Jan 2025 | $18.5B |
| Oct 2024 | $21.1B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+11.0%
TTM free cash flow over market value at close 2026-10-23
FCF yield CPB
| FY Aug 2026 | +10.3% |
| FY Aug 2025 | +7.3% |
| FY Jul 2024 | +4.8% |
| FY Jul 2023 | +5.6% |
| FY Jul 2022 | +6.3% |
| Aug 2026 | +10.3% |
| May 2026 | +10.9% |
| Feb 2026 | +8.3% |
| Nov 2025 | +7.7% |
| Aug 2025 | +7.3% |
| Apr 2025 | +6.7% |
| Jan 2025 | +6.7% |
| Oct 2024 | +5.4% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -35%, PEG needs growth
PEG, trailing CPB
| FY Aug 2026 | n/a |
| FY Aug 2025 | 2.33x |
| FY Jul 2024 | n/a |
| FY Jul 2023 | 1.20x |
| FY Jul 2022 | n/a |
| Aug 2026 | n/a |
| May 2026 | 0.29x |
| Feb 2026 | 2.18x |
| Nov 2025 | 2.36x |
| Aug 2025 | 2.33x |
| Apr 2025 | n/a |
| Jan 2025 | n/a |
| Oct 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2026-08 | 2025-08 | 2024-07 | 2023-07 | |
|---|---|---|---|---|
| Revenue | $9.7B | $10.3B | $9.6B | $9.4B |
| Operating income | $852.0M | $1.1B | $1.0B | $1.3B |
| Net income | $405.0M | $602.0M | $567.0M | $858.0M |
| EPS (diluted) | 1.31 | 2.01 | 1.89 | 2.85 |
| Operating cash flow | $1.0B | $1.1B | $1.2B | $1.1B |
| Cash | $394.0M | $132.0M | $108.0M | $189.0M |
| Long-term debt | $6.2B | $6.1B | $5.8B | $4.5B |
| Buybacks | $26.0M | $62.0M | $67.0M | $142.0M |
| Dividends paid | $470.0M | $459.0M | $445.0M | $447.0M |
SEC XBRL, fiscal years, as known on 2026-10-27
CPB Stock Sonar score 6/7 axes
Find similar shapesCompareCPB ranks highest on risk and compliance (65th percentile) and profitability (53rd), and lowest on growth (27th), among Food & Beverage peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CPB filings, in plain words
Are Campbell's insiders buying or selling CPB?
In the 180 days to 2026-10-27, Campbell's insiders were net buyers, a net $2.1K across purchases and sales reported on Form 4, by 1 buyer.
Have members of Congress traded CPB?
Yes. In the year to 2026-10-27, 1 House member disclosed buying CPB and 1 House member disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-05-15.
Read the full summary
In the 180 days to 2026-10-27, Campbell's insiders were net buyers of CPB, a net $2.1K across purchases and sales reported on Form 4 by 1 buyer. In the year to 2026-10-27, 1 member of Congress disclosed buying CPB and 1 member disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-05-15. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
